Mechanism-based model of the pharmacokinetics of enfuvirtide, an HIV fusion inhibitor (Q1788684): Difference between revisions
From MaRDI portal
Created claim: Wikidata QID (P12): Q36675928, #quickstatements; #temporary_batch_1711439739529 |
Normalize DOI. |
||
(One intermediate revision by one other user not shown) | |||
Property / DOI | |||
Property / DOI: 10.1016/j.jtbi.2007.12.017 / rank | |||
Property / cites work | |||
Property / cites work: Q3236921 / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: INFLUENCE OF DRUG PHARMACOKINETICS ON HIV PATHOGENESIS AND THERAPY / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Q4275389 / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Drug concentration heterogeneity facilitates the evolution of drug resistance / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Q4313022 / rank | |||
Normal rank | |||
Property / DOI | |||
Property / DOI: 10.1016/J.JTBI.2007.12.017 / rank | |||
Normal rank |
Latest revision as of 10:14, 16 December 2024
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Mechanism-based model of the pharmacokinetics of enfuvirtide, an HIV fusion inhibitor |
scientific article |
Statements
Mechanism-based model of the pharmacokinetics of enfuvirtide, an HIV fusion inhibitor (English)
0 references
8 October 2018
0 references
antiretroviral therapy
0 references
subcutaneous administration
0 references
intravenous administration
0 references
multiple dose pharmacokinetics
0 references